BioRestorative Therapies, Inc.
BRTX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001505497
No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in BioRestorative Therapies, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −1 vs. Q4 2022
- Shares held
- 299.1K
- −29.0K (−8.8%) vs. Q4 2022
- Total value
- $1.02M
- +$117.1K (+13.0%) vs. Q4 2022
- New holders
- 3
- 1 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.00M |
| Q1 2026 | 14 | $184.2K |
| Q4 2025 | 16 | $383.4K |
| Q3 2025 | 17 | $550.3K |
| Q2 2025 | 18 | $413.9K |
| Q1 2025 | 17 | $501.8K |
| Q4 2024 | 17 | $405.6K |
| Q3 2024 | 17 | $471.9K |
| Q2 2024 | 15 | $520.0K |
| Q1 2024 | 15 | $531.0K |
| Q4 2023 | 15 | $540.9K |
| Q3 2023 | 15 | $648.7K |
| Q2 2023 | 14 | $1.42M |
| Q1 2023 | 17 | $1.02M |
| Q4 2022 | 18 | $900.4K |
| Q3 2022 | 19 | $1.16M |
| Q2 2022 | 16 | $975.1K |
| Q1 2022 | 17 | $1.80M |
| Q4 2021 | 13 | $1.72M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 2 | $12.0K |
| Q1 2021 | 1 | $30.0K |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding BioRestorative Therapies, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 125,956 | $428.3K | 0.00% | −9,090−6.7% | Reduced |
| Wealth Alliance | 44,316 | $150.7K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 29,100 | $98.9K | 0.00% | +29,100 | New |
| Mariner, LLC | 26,668 | $91.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,459 | $69.6K | 0.00% | +20,459 | New |
| Two Sigma Investments, LP | 17,026 | $57.9K | 0.00% | +17,026 | New |
| StoneX Group Inc. | 14,954 | $50.8K | 0.01% | −3,383−18.4% | Reduced |
| Geode Capital Management, LLC | 13,698 | $46.6K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2,000 | $6.80K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,694 | $5.76K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,595 | $5.42K | 0.00% | +1,594+159,400.0% | Added |
| Tower Research Capital LLC (TRC) | 1,212 | $4.00K | 0.00% | −2,969−71.0% | Reduced |
| Householder Group Estate & Retirement Specialist, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 201 | $683 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 22 | $75 | 0.00% | 00.0% | Unchanged |
| JJJ Advisors Inc. | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Ayrton Capital LLC | 0 | $0 | 0.00% | −41,374−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −28,050−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −12,296−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |